Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
<p><strong>Background</strong></p> The effects of pharmacological blood-pressure-lowering on cardiovascular outcomes in individuals aged 70 years and older, particularly when blood pressure is not substantially increased, is uncertain. We compared the effects of blood-pressur...
Main Authors: | Rahimi, K, Nazarzadehlarzjan, M, Bidel, Z, Copland, E, Canoy, D, Wamil, M, Majert, J, McManus, RJ |
---|---|
Other Authors: | The Blood Pressure Lowering Treatment Trialists’ Collaboration |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2021
|
Similar Items
-
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
by: Nazarzadeh Larzjan, M, et al.
Published: (2021) -
Sex-specific effects of blood pressure lowering pharmacotherapy for the prevention of cardiovascular disease: an individual participant-level data meta-analysis
by: Bidel, Z, et al.
Published: (2023) -
Blood pressure meta-analysis highlights an implementation gap - authors' reply
by: Rahimi, K, et al.
Published: (2022) -
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
by: Rahimi, K, et al.
Published: (2019) -
How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?
by: Canoy, D, et al.
Published: (2022)